Nutriband Inc.

Stage 2 · Advancing · week 6

As of Oct 22, 2026, Nutriband is in Stage 2, the uptrend phase, now in week 6 (since Sep 17, 2026). It closed at $5.81, 35.4% below its 52-week high and above its 200-day average, which is rising.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. More about the company

$5.81

-5.37% today

$70.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is NTRB early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 21w

S4 39w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 3w → S2 1w → S1 2w → S4 12w → S1 11w → S4 4w → S1 1w → S2 21w → S3 7w → S2 6w → S3 3w → S4 5w → S1 2w → S2 8w → S3 8w → S2 11w → S3 9w → S2 3w → S3 1w → S4 39w → S1 3w → S2 5w current

Total tracked: 164 weeks across 22 stage runs.

NTRB among Biotechnology248th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…248	NTRBNutriband Inc.	Stage 2 · wk 6	39	−21.0%

vs 52W High

-35.4%

$2.81 lo$8.99 hi

35.4% below 52W high, far from high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

34.7%

200 DMA: $4.31 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.20x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-21.0%

+95.0%

+44.9%

YTD

+31.2%

-20.1%

Scan Membership

Breakout Watch

Latest: 2025-06-12

6 appearances in last 60 days. First seen: 2022-08-29.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 6 · Vol 0.20x

2026-10-21S2

Wk 5 · Vol 0.26x

2026-10-20S2

Wk 5 · Vol 0.20x

2026-10-19S2

Wk 5 · Vol 0.97x

2026-10-16S2

Wk 5 · Vol 0.34x

2026-10-15S2

Wk 5 · Vol 0.88x

2026-10-14S2

Wk 4 · Vol 0.65x

2026-10-13S2

Wk 4 · Vol 0.89x

2026-10-12S2

Wk 4 · Vol 0.20x

2026-10-09S2

Wk 4 · Vol 0.59x

2026-10-08S2

Wk 4 · Vol 0.47x

2026-10-07S2

Wk 3 · Vol 0.13x

Moving averages & range

50 DMA

$6.03

200 DMA

$4.31

52W High

$8.99

52W Low

$2.81

5D Low

$5.81

Resistance levels (recent highs)

20d High

$8.25

60d High

$8.99

120d High

$8.99

250d High

$8.99

Next resistance

+42.0%

to 20d High

ROE

-100.7%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 13.3

Nutriband: quick answers

What stage is Nutriband in?

As of Oct 22, 2026, Nutriband (NTRB) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 17, 2026 and is in week 6. What the four stages mean

Is Nutriband in an uptrend?

Yes. Nutriband is in a Stage 2 uptrend. It trades 34.7% above its 200-day average, which is rising.

How far is Nutriband from its 52-week high?

Nutriband closed at $5.81 on Oct 22, 2026, 35.4% below its 52-week high of $8.99. Its 52-week low is $2.81.

How has Nutriband performed over the past year?

As of Oct 22, 2026, Nutriband is down 20.1% over the past year and up 31.2% so far in 2026.

Which sector and industry is Nutriband in?

Nutriband is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.